En Es
Categories

Industry News


Transasia Showcases Clinical Lab Solutions at APPI 2017

By Labmedica International staff writers
16 Jun 2017

Image: The Sysmex XN-330 hematology analyzer, one of three analyzers showcased at the APPI 2017 conference (Photo courtesy of Transasia).Transasia Bio-Medicals Ltd. (Mumbai, India), an in-vitro diagnostic company, will be the technology partner as well as principal partner of the 4th Annual Conference hosted by the Association of Practicing Pathologists of India (APPI-Mumbai), held June 16-18, 2017, in Mumbai, India.

Transasia, a part of the global Erba Diagnostics Mannheim GmbH Group, offers solutions and products in biochemistry, hematology, coagulation, ESR, immunology, urinalysis, critical care, diabetes management, microbiology and molecular diagnostics. During the three-day event, which will be attended by over 1,000 practicing pathologists from India and across the world, the company will introduce new products and processes that provide an end-to-end solution for improved lab efficiency. Transasia will be introducing Sysmex XN-330, the latest six-part differential hematology analyzer as well as showcasing the EM 200, a fully automated biochemistry analyzer, and the ECL 760 coagulation analyzer.

Additionally, Transasia will also organize interactive scientific sessions and workshops led by experienced industry veterans in the fields of hematology, biochemistry and coagulation. This will provide an important forum for practicing pathologists and lab owners to engage in a dialogue about critical compliance and operational challenges, as well as open the doors for further discussions on the best practice approaches for addressing those challenges.



E-mail Print
FaceBook Twitter Google+ Linked in

ERBA MANNHEIM

Erba Diagnostics Mannheim, a company registered in Mannheim, Germany supplies Instruments, Reagents and Consumables conforming to IVD Directives.  It is a ISO 13485 : 2003 certified company. The requisite expertise and technical edge have made Erba “The Company of Choice” for supplying instruments under OEM labels for many diagnostic companies across Europe and Asia.
Gold member
More info

Additional news

19 Apr 2018
Seegene Unveils Combination Test at ECCMID 2018
Seegene Inc., a developer of multiplex PCR technologies, introduced a combination test at the 28th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2018) held in Madrid, Spain, from April 21 to 24, 2018. The combination test is a high-efficiency solution that diagnoses various causes of diseases with multiplex molecular diagnosis assays. Seegene also showcased its molecular diagnostic system SGSTAR (Seegene Sameday Test and Report), which allows order-to-report on the same day and enables the running of the combination test.
Read More
18 Apr 2018
Breast Imaging Market Worth USD 7 Billion by 2024
The global breast imaging market size was estimated at USD 2.9 billion in 2016 and is expected to reach USD 7.3 billion by 2024, driven by the increasing prevalence of breast cancer and other breast-related diseases such as infections, lesions and fibrocysts, as well as supportive government initiatives to increase awareness.
Read More
17 Apr 2018
Veritas Capital Acquires IT Unit of GE Healthcare
Veritas Capital, a private equity investment firm, has entered into a definitive agreement with General Electric, to acquire the Enterprise Financial Management (Revenue-Cycle, Centricity Business), Ambulatory Care Management (Centricity Practice Solution) and Workforce Management (formerly API Healthcare) assets comprising GE Healthcare’s Value-Based Care Division for USD 1.05 billion in cash.
Read More
16 Apr 2018
Interactive VR Assists in Treatment Planning
Interactive virtual reality (VR) shows a patient's unique internal anatomy to interventional radiologists in order to help physicians effectively prepare and tailor their approach to complex treatments, such as splenic artery aneurysm repair. In a new study, researchers compared the VR technology to the use of images from a commonly used visualization software system that displays images on a standard two-dimensional platform and found the accuracy to be similar with both methods, though confidence improved substantially with VR.
Read More
05 Apr 2018
New AI Technique Dramatically Improves Quality of Medical Imaging
Researchers have developed a new technique based on artificial intelligence (AI) and machine learning that enables radiologists to acquire higher quality images without having to collect additional data at the cost of increased radiation dose for computed tomography (CT) and positron emission tomography (PET) or uncomfortably long scan times for magnetic resonance imaging (MRI).
Read More
05 Apr 2018
Canon Medical Systems Initiates Collaborative Research On AI in MR Imaging
Canon Medical Systems Corporation, along with Kumamoto University and the University of Bordeaux, has initiated collaborative research on the application of Deep Learning Reconstruction (DLR), an Artificial Intelligence (AI)-based technology in magnetic resonance (MR) imaging.
Read More
04 Apr 2018
Dissecting AI to Better Understand the Human Brain
At the 25th annual meeting of the Cognitive Neuroscience Society (CNS), researchers presented their work in which cognitive neuroscientists are increasingly using emerging artificial networks to enhance their understanding of one of the most elusive intelligence systems, the human brain. Among the work presented at the symposium at the CNS annual meeting held in Boston from March 24-27, 2018, was “Human and machine cognition: The deep learning challenge” by Aude Oliva of MIT. In Oliva’s work, neuroscientists are learning much about the role of contextual clues in human image recognition. By using “artificial neurons” – essentially lines of code, software – with neural network models, they can parse out the various elements that go into recognizing a specific place or object.
Read More
04 Apr 2018
POC Glucose Monitoring Devices Market to Reach USD 2 Billion in 2022
The global POC blood glucose monitoring devices market is expected to reach USD 2.03 billion in 2022, driven mainly by public and private initiatives to reduce diabetic cases. However, the high cost associated with diabetes management is one of the major factors hindering the market growth.
Read More
03 Apr 2018
Top 3 Trends Impacting Global X-Ray Detector Market
The global X-ray detectors market is expected to grow at a CAGR of 5.6% from USD 2.53 billion in 2017 to USD 3.31 billion by 2022, driven mainly by increasing public and private investments in digital imaging technologies, declining prices and benefits offered by digital detectors, and reimbursement cuts for analog X-rays. However, the high cost of digital X-ray systems may limit the market growth to some extent. Nevertheless, the introduction of wireless X-ray detectors, growing medical tourism in the developing countries and numerous growth avenues in the emerging markets will provide opportunities for the global X-ray detectors market.
Read More
Copyright © 2000-2018 TradeMed.com. All rights reserved. | Terms And Conditions